US Patent 11707480 Highly active compounds against COVID-19
Patent 11707480 was granted and assigned to Atea Pharmaceuticals, Inc. on July, 2023 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 11707480 Highly active compounds against COVID-19
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
